DOCSLIB.ORG

Recommendations for the Reporting of Tissues Removed As Part of The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Recommendations for the Reporting of Tissues Removed As Part of The Recommendations for the Reporting of Tissues Removed as Part of the Surgical Treatment of Common Malignancies of the Eye and its Adnexa Robert Folberg, M.D., Diva Salomao, M.D., Hans E. Grossniklaus, M.D., Alan D. Proia, M.D., Ph.D., Narsing A. Rao, M.D., J. Douglas Cameron, M.D. University of Illinois at Chicago (RF), Chicago, Illinois; The Mayo Clinic (DS, JDC), Rochester, Minnesota; Emory University (HEG), Atlanta, Georgia; Duke University (ADP), Durham, North Carolina; and The Keck School of Medicine (NAR)-University of Southern California, Los Angeles, California The purpose of these recommendations is to pro- The Association of Directors of Anatomic and Sur- vide an informative report for the clinician. The gical Pathology developed recommendations for the recommendations are intended as suggestions, and surgical pathology report for common malignant adherence to them is completely voluntary. In spe- tumors. The recommendations for tumors of the cial circumstances, the recommendations may not eye and its adnexa are reported. be applicable. The recommendations are intended as an educational resource rather than a mandate. KEY WORDS: Basal cell carcinoma, Conjunctiva, Eyelid, Melanoma, Orbit Retinoblastoma, Seba- ceous carcinoma, Squamous cell carcinoma, Uvea. BACKGROUND Mod Pathol 2003;16(7):725–730 Before the public awareness of AIDS and Alzhei- The Association of Directors of Anatomic and mer’s disease as health problems, the disease Surgical Pathology named several committees to feared most by Americans was cancer; the second develop recommendations about the content of the most feared condition was blindness (The Gallup surgical pathology report for common malignant Organization, Inc., Public knowledge and attitudes tumors. A committee of persons with special inter- concerning blindness—a survey sponsored by Re- est and expertise write the recommendations, search to Prevent Blindness, Inc., New York, Octo- which are reviewed and approved by the council of ber 1965 and April 1976, unpublished data). Pa- Association of Directors of Anatomic and Surgical tients who are confronted with a diagnosis of ocular Pathology and subsequently by the entire cancer, therefore, face two of their most principal membership. fears: shortening of their lifespan and loss of vision. The recommendations have been divided into Ophthalmologists who manage most patients with four major areas: 1) items that provide an informa- ocular malignancies often try to balance the pa- tive gross description; 2) additional diagnostics fea- tient’s desire to preserve vision with the goal of tures recommended for inclusion in every report if eradicating the cancer. In general, the pathologist’s possible; 3) optional features that may be included report should catalog not only those features ap- in the final report; and 4) a checklist. propriate for estimating the natural history of the patient’s disease (prognosis), but also those fea- tures that might compromise vision. Copyright © 2003 by The United States and Canadian Academy of In general, it is recommended that pathologists Pathology, Inc. report on malignancies of the orbit using formats VOL. 16, NO. 7, P. 725, 2003 Printed in the U.S.A. Date of acceptance: February 26, 2003. either published or in development for the coun- The authors were the members of an ad hoc committee of the Association terpart lesion elsewhere in the body. For example, of Directors of Anatomic and Surgical Pathology chaired by Robert Fol- berg, M.D., Chicago, Illinois. lymphomas of the orbit should be reported accord- Address reprint requests to: Robert Folberg, M.D., University of Illinois at ing to generalized recommendations for reporting Chicago, Department of Pathology (MC 847), 1819 West Polk Street, Room 446, Chicago, IL 60612-7335. lymphomas. It is reasonable for the report for rhab- Note: Ophthalmic pathologists use the term “primary acquired melanosis domyosarcoma (the most common primary malig- with atypia” in place of the following terms: intraepithelial atypical mela- nocytic hyperplasia, malignant melanoma in situ, Level I malignant nancy of the orbit in childhood in the United melanoma. States) to follow recommendations for reporting DOI: 10.1097/01.MP.0000076978.06324.EE rhabdomyosarcomas in general. The lacrimal gland 725 may be considered to be a minor salivary gland for 7. Orientation of the lesion if provided by the the purposes of reporting malignancies in this re- surgeon gion, and pathology reports dealing with lacrimal 1. Some surgeons will identify surgical margins of gland malignancies (principally adenoid cystic car- interest by applying a suture to an edge of the cinoma) should follow recommendations for re- specimen, by painting certain margins with dyes, or porting this tumor as described for the salivary attaching the specimen to a piece of filter paper and gland. making notations on the specimen mount Recommendations are therefore offered for three B. Iridectomy/iridocyclectomy classes of ocular malignancies: conjunctival neo- 1. Dimensions of the specimen (length, width, plasms (including those affecting the limbus—the thickness) junction between the cornea and sclera), sebaceous 2. Description of tissue received (iris only, iris and carcinoma (a common malignancy of the eyelid), ciliary body, iris, ciliary body and peripheral cornea and the two major intraocular neoplasms (retino- and/or sclera including location by clock hour) blastoma and malignant melanoma). 3. Dimensions of lesion (length, width, height) 1. General –the Association recommends that the 4. Measurement of minimum distance between following features be included in the final report edge of lesion and surgical margin (minimum because they are generally accepted as being of clearance) prognostic importance, of visual importance, re- 1. Relevant surgical margins include the lateral quired for staging or therapy, and/or traditionally margins and the posterior margin (the anterior expected. margin is the pupillary border and is not a true A. How the specimen was received (e.g., fresh or surgical margin) in fixative) C. Enucleation B. How the specimen was identified (e.g., labeled 1. Dimensions of the eye (anterior-posterior, hor- with the name, medical record number, and sur- izontal, vertical) geon’s name) 2. Length of optic nerve attached C. Laterality of the lesion (e.g., originating from 3. Examination of the surface of the eye for gross the right or left eye) evidence of extraocular extension of tumor D. The exact anatomic location of the tumor 4. Dimensions of the cornea (horizontal and 1. Conjunctiva: bulbar (by quadrant –superior, vertical) inferior, nasal, temporal), palpebral (superior or in- 5. Clarity of the cornea ferior), fornix (superior or inferior) 6. Color of the iris (describe lesions if present) 2. Limbus (by clock hour) 7. Shape and diameter of the pupil 3. Caruncle or plica semilunaris 8. Transillumination of the eye with dimensions 4. Eyelid (upper, lower, medial canthus, lateral of any shadows canthus) 1. Transillumination of the eye may be performed 5. Intraocular tissue (iris, ciliary body –by clock with a fiberoptic light source to locate a tumor hour) within the eye by the shadow that it casts during E. The type of surgical procedure this procedure 1. Incisional biopsy, excisional biopsy, shave bi- 1. Location of transillumination shadow(s) rela- opsy (conjunctiva, eyelids) tive to the limbus and optic nerve (distance of 2. Iridectomy (removal of iris tissue), iridocyclec- shadow borders from limbus and optic nerve) tomy (removal of iris and ciliary body tissue) 2. Location of the shadow relative to clock hour 3. Enucleation (removal of eye) 9. Describe the section plane used to open the 4. Exenteration (removal of the eye and orbital eye contents, with or without eyelids, not covered in 10. Obtain cross section of the optic nerve this report) 1. Retinoblastoma 2. Gross Description 1. Obtain a section from either the surgical mar- A. Conjunctival and Eyelid Biopsy gin of the optic nerve (the transected edge) or the 1. Dimensions of the specimen (length, width, cut surface of the optic nerve as it inserts in the eye thickness) 1. If the cut section of the optic nerve adjacent to 2. Maximum diameter of any visible lesion the eye is negative for tumor, then one may con- 3. Measurement of minimum distance between clude that there is no involvement of the nerve edge of lesion and surgical margin (minimum posterior to the eye (tumor extends through the clearance) nerve without skip lesions) 4. Presence or absence of ulceration 2. Frequently, the surgical margin of the optic 5. Color of the lesion and adjacent tissue nerve (the cut edge of the nerve) is crushed by 6. Description of attached tissue (episclera, enucleation scissors cornea) 11. Describe the cut surface of the eye 726 Modern Pathology 1. Retinoblastoma modification of the Breslow method using a cali- 1. Number and size of lesions brated ocular micrometer. The tumor thickness is 2. Location of the lesion(s) measured from the top of the epithelium (there is 3. Gross evidence of choroidal invasion or ex- no granular layer in the normal conjunctival traocular extension epithelium). 4. Presence or absence of vitreous seeding 1. Some pathologists consider a depth of invasion 5. Presence or absence of retinal detachment of 0.8 mm to be significant in separating patients at 2. Uveal melanoma high risk for metastasis from those at low risk. 1. Tissues involved (choroid only, choroid and 4. Intralymphatic invasion by tumor ciliary body, ciliary body only, iris and ciliary body, 5. Optional criteria iris only) 1. Mitotic figures/mm2; proliferation indices us- 2. Location of the melanoma relative to clock ing markers such as MIB-1 or Ki67 hour C. Sebaceous carcinoma of the eyelid 3. Dimensions from cut surface (maximum zone 1. Location of the tumor (upper eyelid versus of scleral contact, dimension perpendicular to max- lower eyelid) imum zone of scleral contact, elevation measured 2. Size in millimeters from top of lesion to interface with sclera) 1. Some pathologists consider this measurement 4.
Load more

Recommended publications
  • Is a Wider Margin (2 Cm Vs. 1 Cm) for a 1.01–2.0 Mm Melanoma Necessary?
    Ann Surg Oncol DOI 10.1245/s10434-016-5167-6 ORIGINAL ARTICLE – MELANOMAS Is a Wider Margin (2 cm vs. 1 cm) for a 1.01–2.0 mm Melanoma Necessary? Matthew P. Doepker, MD1, Zachary J. Thompson, PhD2, Kate J. Fisher, MA2, Maki Yamamoto, MD3, Kevin W. Nethers, MS1, Jennifer N. Harb, MD1, Matthew A. Applebaum, MS1, Ricardo J. Gonzalez, MD1, Amod A. Sarnaik, MD1, Jane L. Messina, MD4, Vernon K. Sondak, MD1, and Jonathan S. Zager, MD, FACS1 1Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL; 2Department of Biostatistics, Moffitt Cancer Center, Tampa, FL; 3Department of Surgical Oncology, University of California, Irvine Medical Center, Orange, CA; 4Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL ABSTRACT Wider margins were associated with more frequent graft or Background. The current NCCN recommendation for flap use only on the head and neck (p = 0.025). resection margins in patients with melanomas between 1.01 Conclusions. Our data show that selectively using a nar- and 2 mm deep is a 1–2 cm radial margin. We sought to rower margin of 1 cm did not increase the risk of LR or determine whether margin width had an impact on local decrease DSS. Avoiding a 2 cm margin may decrease the recurrence (LR), disease-specific survival (DSS), and type need for graft/flap use on the head and neck. of wound closure. Methods. Melanomas measuring 1.01–2.0 mm were evaluated at a single institution between 2008 and 2013. The incidence of melanoma in the United States con- All patients had a 1 or 2 cm margin.
    [Show full text]
  • Evaluation of All Surgical Margins in Pancreatic Resection Specimens by Proper Grossing Techniques: Surgical Pathology Experience of 285 Cases
    Original Article doi: 10.5146/tjpath.2018.01426 Evaluation of All Surgical Margins in Pancreatic Resection Specimens by Proper Grossing Techniques: Surgical Pathology Experience of 285 Cases Özgür EKİNCİ Department of Medical Pathology, Gazi University Faculty of Medicine, ANKARA, TURKEY ABSTRACT Objective: The aim of this study was to review our series of pancreatic resection specimen handling results and focus on the positivity of the tumor in various retroperitoneal surgical margins. Material and Method: Our archival cases from 2008 to 2018 were retrospectively examined, especially for the surgical margins. The demographics, tumor locations, and the diagnoses were recorded. The state of all of the retropancreatic surgical margins (anterior, posterior, superior, inferior, superior mesenteric vein and artery) were recorded. Results: There were 285 cases, of which 157 were male and 128 female. The mean and median ages were 63.3 and 64, respectively. Invasive ductal adenocarcinoma was the most common diagnosis [202 cases (70.8%)]. Positivity was observed in 90 (31.5%) margins. The majority was in the superior mesenteric vein margin [n:24 (8.4%)]. This was followed by the anterior, resection and SMA margins. Conclusion: Pancreatic resections should macroscopically be sampled by recommended methods in order to detect positivity in individual margins by proper grossing techniques. When this is applied, the superior mesenteric vein margin is the margin most prone to be positive for the tumor. Key Words: Pancreatic cancer, Surgical margin, Macroscopy INTRODUCTION the time of diagnosis and the location of the tumor in the pancreas were recorded. Tumor locations were grouped as Surgical resection is the only curative treatment option for patients with pancreatic adenocarcinoma (1).
    [Show full text]
  • A Practical Guide to Frozen Section Technique Stephen R
    A Practical Guide to Frozen Section Technique Stephen R. Peters Editor A Practical Guide to Frozen Section Technique Editor Stephen R. Peters University of Medicine and Dentistry of New Jersey New Jersey Medical School Newark, NJ USA [email protected] ISBN 978-1-4419-1233-6 e-ISBN 978-1-4419-1234-3 DOI 10.1007/978-1-4419-1234-3 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2009933112 © Springer Science+Business Media, LLC 2010 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) Preface Frozen section technique is a valuable tool used to rapidly prepare slides from tis- sue for microscopic interpretation. Frozen section technique is used in a myriad of clinical and research settings. In surgical pathology, frozen sections are routinely used for rapid intra-operative diagnosis, providing guidance for our surgical col- leagues.
    [Show full text]
  • (R0) in Pancreatic Cancer Resections
    Cancers 2010, 2, 2001-2010; doi:10.3390/cancers2042001 OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Review Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections Anna Melissa Schlitter 1 and Irene Esposito 1,2,* 1 Institute of Pathology, Technische Universität München, Ismaningerstr. 22, 81675 Munich Germany; E-Mail: [email protected] 2 Institute of Pathology, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 30 October 2010 / Accepted: 17 November 2010 / Published: 25 November 2010 Abstract: To date, curative resection is the only chance for cure for patients suffering from pancreatic ductal adenoacarcinoma (PDAC). Despite low reported rates of microscopic tumor infiltration (R1) in most studies, tumor recurrence is a common finding in patients with PDAC and contributes to extremely low long-term survival rates. Lack of international definition of resection margins and of standardized protocols for pathological examination lead to high variation in reported R1 rates. Here we review recent studies supporting the hypothesis that R1 rates are highly underestimated in certain studies and that a microscopic tumor clearance of at least 1 mm is required to confirm radicality and to serve as a reliable prognostic and predictive factor. Keywords: pancreatic cancer; resection margin; R1; definition of resection status; pathological standardization 1. Introduction Pancreatic ductal adenoacarcinoma (PDAC) is one of the most aggressive tumors with an extremely poor prognosis. Despite recent advances in surgical treatment and adjuvant therapy, the survival rates are still very low (five-year survival about 5%) [1,2].
    [Show full text]
  • The Prognostic Role of the Surgical Margins in Squamous Vulvar Cancer: a Retrospective Australian Study
    cancers Article The Prognostic Role of the Surgical Margins in Squamous Vulvar Cancer: A Retrospective Australian Study Ellen L. Barlow 1,*, Michael Jackson 2,3 and Neville F. Hacker 1,4 1 Gynaecological Cancer Centre, Royal Hospital for Women, Sydney 2031, Australia; [email protected] 2 Radiation Oncology Department, Prince of Wales Hospital, Sydney 2031, Australia; [email protected] 3 Prince of Wales Clinical School, University of New South Wales, Sydney 2052, Australia 4 School of Women’s & Children’s Health, University of New South Wales, Sydney 2052, Australia * Correspondence: [email protected]; Tel.: +61-2-93826184 Received: 30 September 2020; Accepted: 9 November 2020; Published: 14 November 2020 Simple Summary: Squamous cell carcinoma of the vulva is a rare disease, but cure rates are good if managed appropriately. The need for radical vulvectomy was initially challenged about 40 years ago for lesions 1 2 cm diameter. Since then, there has been progressive acceptance of radical local excision − for most unifocal squamous vulvar cancers. Originally, a surgical margin of 3 cm around the primary cancer was considered appropriate. Subsequently, a 1 cm margin was generally accepted, but this has become the subject of recent debate. The aims of this study were to determine survival following conservative vulvar resection, and to determine the clinicopathological predictors associated with vulvar recurrence, focusing on the surgical margin. In multivariable analysis, primary site recurrences were increased in patients with margins < 8 mm, and all vulvar and primary site recurrences in patients with margins < 5 mm. Treatment of close or positive margins decreased the risk of recurrence.
    [Show full text]
  • Guidelines for the Management of Cutaneous Melanoma 2010 J.R
    BJD BAD GUIDELINES British Journal of Dermatology Revised U.K. guidelines for the management of cutaneous melanoma 2010 J.R. Marsden, J.A. Newton-Bishop,* L. Burrows, M. Cook,à P.G. Corrie,§ N.H. Cox,– M.E. Gore,** P. Lorigan, R. MacKie,àà P. Nathan,§§ H. Peach,–– B. Powell*** and C. Walker University Hospital Birmingham, Birmingham B29 6JD, U.K. *University of Leeds, Leeds LS9 7TF, U.K. Salisbury District Hospital, Salisbury SP2 8BJ, U.K. àRoyal Surrey County Hospital NHS Trust, Guildford GU2 7XX, U.K. §Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, U.K. –Cumberland Infirmary, Carlisle CA2 7HY, U.K. **Royal Marsden Hospital, London SW3 6JJ, U.K. The Christie NHS Foundation Trust, Manchester M20 4BX, U.K. ààUniversity of Glasgow, Glasgow G12 8QQ, U.K. §§Mount Vernon Hospital, London HA6 2RN, U.K. ––St James’s University Hospital, Leeds LS9 7TF, U.K. ***St George’s Hospital, London SW17 0QT, U.K. Correspondence Disclaimer Jerry Marsden. These guidelines reflect the best published data available at the time the report was E-mail: [email protected] prepared. Caution should be exercised in interpreting the data; the results of future Accepted for publication studies may require alteration of the conclusions or recommendations in this report. 24 May 2010 It may be necessary or even desirable to depart from the guidelines in the interests of Key words specific patients and special circumstances. Just as adherence to the guidelines may not evidence, guideline, investigation, melanoma, treatment constitute defence against a claim of negligence, so deviation from them should not necessarily be deemed negligent.
    [Show full text]
  • Does Surgical Margin Width Remain a Challenge for Triple-Negative Breast Cancer? a Retrospective Analysis
    medicina Article Does Surgical Margin Width Remain a Challenge for Triple-Negative Breast Cancer? A Retrospective Analysis 1,2 1,2 2 2 Eduard-Alexandru Bonci ,S, tefan T, ît, u , Alexandru Marius Petrus, an , Claudiu Hossu , Vlad Alexandru Gâta 1,2, Morvarid Talaeian Ghomi 1, Paul Milan Kubelac 1,3,* , Teodora Irina Bonci 1, 1,3 1,3 1 1,4 Andra Piciu , Maria Cosnarovici , Liviu Hît, u , Alexandra Timea Kirsch-Mangu , 1,4 1,2, 1,2 1,5 Diana Cristina Pop , Ioan Cosmin Lisencu *, Patriciu Achimas, -Cadariu , Doina Piciu , Hank Schmidt 6,7 and Bogdan Fetica 1,8 1 11th Department of Oncological Surgery and Gynecological Oncology, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania; [email protected] (E.-A.B.); [email protected] (S, .T, .); [email protected] (V.A.G.); [email protected] (M.T.G.); [email protected] (T.I.B.); [email protected] (A.P.); [email protected] (M.C.); [email protected] (L.H.); [email protected] (A.T.K.-M.); [email protected] (D.C.P.); [email protected] (P.A.-C.); [email protected] (D.P.); [email protected] (B.F.) 2 Department of Surgical Oncology, “Prof. Dr. Ion Chiricut, ă” Institute of Oncology, 400015 Cluj-Napoca, Romania; [email protected] (A.M.P.); [email protected] (C.H.) 3 Department of Medical Oncology, “Prof. Dr. Ion Chiricut, ă” Institute of Oncology, 400015 Cluj-Napoca, Romania 4 Department of Radiotherapy, “Prof. Dr. Ion Chiricut, ă” Institute of Oncology, 400015 Cluj-Napoca, Romania 5 Department of Nuclear Medicine, “Prof.
    [Show full text]
  • Margin Analysis Cutaneous Malignancy of the Head and Neck
    Margin Analysis Cutaneous Malignancy of the Head and Neck Donita Dyalram, DDS, MDa,*, Steve Caldroney, DDS, MDa, Jonathon Heath, MDb KEYWORDS Margin analysis Cutaneous malignancy Margins of skin cancers Basal cell carcinoma Squamous cell carcinoma Cutaneous melanoma KEY POINTS Frozen section analysis of basal cell carcinoma and squamous cell carcinoma is best accessed by complete circumferential and peripheral and deep margin assessment (CCPDMA) or Mohs micro- graphic surgery. Pan cytokeratin stains can be used in challenging cases. Immunostaining with MART-1 has improved frozen section analysis of cutaneous melanoma. The use of immunostains has made significant strides in frozen section analysis of cutaneous ma- lignant melanoma. INTRODUCTION skin cancer will have occurred before the age of 18 years.1 This article focuses only on margin analysis of The 3 most common types of skin cancer are the cutaneous malignancy of the skin and dis- SCC, BCC, and CMM. Together, SCC and BCC cusses basal cell carcinoma (BCC), squamous are referred to as nonmelanoma skin cancer. It is cell carcinoma (SCC), and cutaneous malignant difficult to accurately assess the number of new melanoma (CMM). The management of the cases of skin cancer each year because they are neck and distant disease are beyond the scope inconsistently accounted for in tumor registries of this article. It answers what is the appropriate due to their high incidence and management in surgical margin when excising these skin tumors, outpatient settings. The current estimate is that validity of frozen section analysis, and what to there are approximately 3.5 million cases diag- do if a positive resection margin is identified nosed in the United States each year.
    [Show full text]
  • Studying Surgical Margin of Skin Melanoma of the Face and Its
    Available online at www.ijmrhs.com International Journal of Medical Research & ISSN No: 2319-5886 Health Sciences, 2016, 5, 8:175-180 Studying Surgical Margin of skin melanoma of the face and its relapse after surgical treatment in patients referring to Razi Hospital and Cancer Institute of Imam Khomeini Hospital during 1992-2010 Mehdi Fathi 1, Ramesh omranipour 1, Ali Jamshidi 2* and Maziyar Amiri 3 1Dept. of Surgery, Tehran University of Medical Science, Iran 2Dept. of Surgery, Hormozgan University of Medical Science, Iran 3Student Research Committee , Hormozgan University of Medical Sciences, Bandar Abbas, Iran _____________________________________________________________________________________________ ABSTRACT Melanoma is a malignant neoplasm caused by the uncontrolled growth of melanocytes and the production of skin pigmentation. Melanoma treatment varies depending on the type and location. To treat melanoma cutaneous (MC), different surgical treatments are used and for histological treatment of the of melanoma lesions, surgical resection is the standard treatment. However, margin optimal resection for treatment of MC is of controversial issues. The aim of this study was to obtain the desired size and safety margins for melanoma surgery, to examine 4-year survival rate, recurrence rate, and its variants in patients with melanoma who underwent surgery were clear margin. The study population was patients diagnosed and hospitalized with melanoma by a pathologist to perform a surgical resection from 1992 until 2010 in the Department of Plastic and Reconstructive Surgery of Razi Hospital and Cancer Institute of Imam Khomeini Hospital. Demographic information of the patients was recorded in the prepared form, and in the first stage of the procedure, with the observed macroscopic lesions margin determined by the anatomical contours.
    [Show full text]
  • Postoperative Radiotherapy for Pancreatic Cancer With
    ANTICANCER RESEARCH 37 : 755-764 (2017) doi:10.21873/anticanres.11374 Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin SUNMIN PARK 1, SONG CHEOL KIM 2, SEUNG-MO HONG 3, YOUNG-JOO LEE 2, KWANG-MIN PARK 2, DAE WOOK HWANG 2, JAE HOON LEE 2, KI-BYUNG SONG 2, BAEK-YEOL RYOO 4, HEUNG-MOON JANG 4, KYU-PYO KIM 4, CHANGHOON YU 4, EUN KYUNG CHOI 1, SEUNG DO AHN 1, SANG-WOOK LEE 1, SANG MIN YOON 1, JIN-HONG PARK 1 and JONG HOON KIM 1 Departments of 1Radiation Oncology, 2Surgery, 3Pathology, and 4Medical Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea Abstract. Aim: To analyze the outcomes in pancreatic It is anatomically difficult to obtain a clear resection cancer (PC) cases with a microscopically-positive resection margin in pancreatic cancer and resection margin margin (R1 resection) treated with postoperative involvement has been established as a key prognostic factor radiotherapy (PORT). Patients and Methods: We in this disease. There is evidence that a higher rate of R1 retrospectively analyzed the outcomes in 62 patients who resection (a microscopically positive margin resection) received PORT for PC with R1 resection between 2001 and relates to poorer survival (4-6). In recent years, there has 2012. All patients received three-dimensional conformal been an increasing interest in the margin status of pancreatic radiotherapy. Concurrent chemotherapy was administered to cancer surgical resection specimens (7). This has been 58 patients. Results: The median follow-up was 20.1 months. mainly trigged by the introduction of a novel pathology The median survival was 22.0 months and the 3-year overall examination technique for pancreatoduodenectomy survival rate was 25%.
    [Show full text]
  • Surgical Resection Margin Classifications for High
    Modern Pathology (2019) 32:1421–1433 https://doi.org/10.1038/s41379-019-0278-9 ARTICLE Surgical resection margin classifications for high-grade pleomorphic soft tissue sarcomas of the extremity or trunk: definitions of adequate resection margins and recommendations for sampling margins from primary resection specimens 1 2 Margaret M. Cates ● Justin M. M. Cates Received: 4 February 2019 / Revised: 29 March 2019 / Accepted: 30 March 2019 / Published online: 3 May 2019 © United States & Canadian Academy of Pathology 2019 Abstract Adequacy of surgical resection margins for soft tissue sarcomas are poorly defined because of the various classifications and definitions used in prior studies of heterogeneous patient cohorts and inconsistent margin sampling protocols. Surgical resection margins of 166 primary, high-grade, pleomorphic sarcomas of the extremity or trunk were classified according to American Joint Committee on Cancer R and Musculoskeletal Tumor Society categories, as well as by metric distance and tissue composition. None of the cases were treated with neoadjuvant therapy. Multivariable competing risk regression 1234567890();,: 1234567890();,: models were evaluated and optimal surgical resection margins for each classification system were defined. Minimum safe tumor clearance was 5 mm without use of adjuvant radiotherapy and 1 mm with adjuvant radiotherapy. Predictive accuracy of margin classification systems was compared by area under receiver-operating characteristic curves generated from logistic regression of 2½-year local recurrence-free survival and other standard tests of diagnostic accuracy. The Musculoskeletal Tumor Society and margin distance classifications performed similarly, both of which showed higher sensitivity and negative predictive value compared to the American Joint Committee on Cancer R classification.
    [Show full text]
  • Bronchial Margins in Lung Cancer Resection Specimens: Utility of Frozen Section and Gross Evaluation
    Modern Pathology (2004) 17, 1080–1086 & 2004 USCAP, Inc All rights reserved 0893-3952/04 $30.00 www.modernpathology.org Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation Susan J Maygarden1,2, Frank C Detterbeck3 and William K Funkhouser1,2 1Department of Pathology; 2Department of Laboratory Medicine and 3Department of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Pathology reports for all lobectomy and pneumonectomy specimens at UNC Hospitals between 1991 and 2000 (n ¼ 405) were reviewed for correlation between frozen section and final bronchial margin, gross distance between tumor and margin and tumor type. Frozen section was performed in 268 cases (66%). A total of 243 were true negatives (90.6 %), 16 (6.0%) were true positives, four (1.5%) were false positives and five (1.9%) were false negatives. The site of tumor in true-positive cases was mucosal (11), submucosal (three), lymphatics (one), peribronchial (one). The site of tumor in false-negative cases was submucosal (two), lymphatics (one), peribronchial (two). In 137 cases, no bronchial frozen section was performed; there was one case (0.7%) with positive margin. There was no correlation between final margin positivity and distance between gross tumor and margin. Tumor distance to margin in positive margin cases varied from grossly involved to 3 cm away. There were 72 cases in which wedge resection was performed before lobectomy in which no gross tumor remained in the lobectomy, and in all cases final bronchial margins were negative. In all, 373 of cases (92%) were nonsmall carcinomas.
    [Show full text]